Multi-physiology modeling of the immune system in the era of precision immunotherapy
Authors:
Open Access
- 29 May 2025
- journal article
- review article
- Published by Frontiers Media SA in Frontiers in Immunology
- Vol. 16, 1548768
Abstract
Immunotherapies using new modalities, including antibody-based drugs, nanoparticle-delivered drugs, and adoptive cell therapy, have become major treatment options for immune-related diseases such as cancer, autoimmune diseases, and infections. Although data characterizing individual patients’ pharmacological responses, immune statuses, and clinical outcomes become increasingly available, predicting individual patients’ immunotherapeutic responses for developing and deploying optimal immunotherapies remains challenging. Here, we propose “multi-physiology modeling” of the immune system that integrates omics-based and dynamic systems modeling-based systems immunology and pharmacometrics modeling on top of basic and clinical immunology. The multi-physiology modeling approach aims to integrate different physiological systems to realistically simulate the multi-scale and complex interactions of the immune system under intervention by immunotherapeutic agents for predictive immunotherapies tailored to individual patients. This will accelerate not only our understanding of basic immunology related to immune-related diseases but also the efficiency and accuracy of clinical immunotherapeutics in the era of precision immunotherapy.Keywords
This publication has 131 references indexed in Scilit:
- Stochastic dynamics of a nonlinear tumor-immune competitive systemNonlinear Dynamics, 2024
- Global stability and parameter analysis reinforce therapeutic targets of PD-L1-PD-1 and MDSCs for glioblastomaJournal of Mathematical Biology, 2023
- Applications of multi‐omics analysis in human diseasesMedcomm, 2023
- Recent applications of quantitative systems pharmacology and machine learning models across diseasesJournal of Pharmacokinetics and Pharmacodynamics, 2021
- Beyond the single average tumor: Understanding IO combinations using a clinical QSP model that incorporates heterogeneity in patient responseCPT: Pharmacometrics & Systems Pharmacology, 2021
- Bench‐to‐bedside translation of chimeric antigen receptor (CAR) T cells using a multiscale systems pharmacokinetic‐pharmacodynamic model: A case study with anti‐BCMA CAR‐TCPT: Pharmacometrics & Systems Pharmacology, 2021
- Nonlinear Mixed‐Effects Model Development and Simulation Using nlmixr and Related R Open‐Source PackagesCPT: Pharmacometrics & Systems Pharmacology, 2019
- Pharmacokinetics of Monoclonal AntibodiesCPT: Pharmacometrics & Systems Pharmacology, 2017
- Mathematical Models for Immunology: Current State of the Art and Future Research DirectionsBulletin of Mathematical Biology, 2016
- Introduction to Population Pharmacokinetic / Pharmacodynamic Analysis with Nonlinear Mixed Effects Models2014